LetsAnalyzeandTalk
@GlobalEconomy15
Followers
10
Following
602
Media
92
Statuses
817
Find the latest #news on global #economy, #politics, #media, #sports and more
Varanasi
Joined August 2022
#Trump imposes 10% tariffs on #Denmark, #Sweden, #Norway, #Finland, #Netherlands, #UnitedKingdom from February 1st. Tariffs to increase to 25% in June
0
0
2
Amid #Trump receiving #NobelPeacePrize from Maria Corina #Machado, the Norwegian Nobel Committee says Nobel Prize and the Laureate Are Inseparable. Says medal and the diploma are only the physical symbols
0
0
0
#India is undergoing massive reforms to transform its economy under #PrimeMinister #NarendraModi. Look at the space to find our latest video on reforms that #India is undergoing to spur further growth. Recently #IMF hailed #India for being fastest growing major #economy
0
0
0
#Vizag alert: PM2.5 levels are above 300, and the AQI is crossing 200. This needs serious consideration for a city that is all set to become the next engine of growth not only for AP but for #India
@naralokesh @GVMC_VISAKHA
thehindu.com
Vizag's air quality deteriorates dangerously, with PM2.5 levels exceeding 300, prompting urgent health warnings and inspections.
0
0
1
#Trump bombed #Venezuela to get control over #oil; however, he cites the drug cartel as the reason. As Fareed Zakaria said, managing drugs is very simple for a country like the #US. Drug seizure data shows that #Venezuela is not as prominent a supplier of #cocaine to the #USA
0
0
0
The trailer of #TheRaajaSaab, starring #India's biggest #superstar #Prabhas, is out! https://t.co/Ft9Owya8M3
0
0
0
#Maharashtra continues to top the chart in terms of #FDI investment in #India Top investment destinations in India between Apr-Sep #Maharastra - 31% #Karnataka - 21% #Gujarat - 15%
0
0
0
#UttarPradesh to become $1 trillion economy by 2029: CM #YogiAdityanath
0
0
0
#Indigo had 53.4% of market share at the end of 2024 in terms of seating capacity
0
0
0
#France’s #HAS Issues Conditional Reimbursement for #JAYPIRCA (Pirtobrutinib) in Relapsed or Refractory Mantle Cell Lymphoma https://t.co/75QjUz9Wbg
#pharma #pharmaceutical #marketaccess #HAS #Oncology #ASH25 #Oncologie #OncoAlert #ESMODailyReporter #Médicaments
0
0
0
Find our #healthcare & #pharmaceutical #consulting services on #fiverr
https://t.co/yk94ymdlta You can also write to info@ipharmacenter.com Our services include #Competitiveintelligence #Pipelinereports #Marketresearch #Marketaccess #Forecasting #news #media #ASH2025 #ASH25
0
0
0
Find our #healthcare & #pharmaceutical #consulting services on #fiverr
https://t.co/yk94ymdlta You can also write to info@ipharmacenter.com Our services include #Competitiveintelligence #Pipelinereports #Marketresearch #Marketaccess #Forecasting #news #media #ASH2025 #ASH25
0
0
0
0
0
0
Efficacy of Anitocabtagene Autoleucel (Anito-cel) in #multiplemyeloma Estimated PFS rates reached 82.1% at 12 months, 67.4% at 18 months, and 61.7% at 24 months, while OS remained high at 94%, 88%, and 83% https://t.co/7GjDCeSDDW
#ASH25 #OncoTwitter #OncoAlert #cancer #oncology
0
0
0
#KitePharma #news
#ASH25 iMMagine-1 pivotal anito-cel in 3L+ RRMM 96% ORR 74% sCR/CR 95% MRD negativity (≤10⁻⁵) at median 1 mo At 15.9 mo: PFS 82% at 12mo, 67% at 18mo Planned 2026 launch. https://t.co/7GjDCeSDDW
#pharma #ASH25 #ASH2025 #hematology #MultipleMyeloma
0
0
0
Efficacy of Anitocabtagene Autoleucel (Anito-cel) Based on an IRC assessment, the therapy produced an overall response rate (ORR) of 96%, with 74% achieving stringent complete or complete response (sCR/CR) https://t.co/7GjDCeSDDW
#ASH25 #OncoTwitter #OncoAlert #cancer #oncology
0
0
0
Efficacy of Anitocabtagene Autoleucel (Anito-cel) in #multiplemyeloma Estimated PFS rates reached 82.1% at 12 months, 67.4% at 18 months, and 61.7% at 24 months, while OS remained high at 94%, 88%, and 83% https://t.co/7GjDCeSDDW
#ASH25 #OncoTwitter #OncoAlert #cancer #oncology
0
0
0
#ASH25 updates on @ipharmacenter
Updated CARTITUDE‑4 results at #ASH25 suggest a potential “treatment‑free remission” fraction with #CARVYKTI in earlier‑line RRMM https://t.co/n62EohAn2J
#ASH2025 #news #media #pharma #breakingnews #oncology #OncoAlert #OncoTwitter #JNJ #Johnsonandjohnson #Cancer #cancercare
0
0
0